Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-002047

Chief Financial Officer bought 2,250 shares at $21.00 ($47,250)

From the SEC's structured data for this filing

Trades in this filing

Trigilio Jeffrey · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-01-12 Purchase : show line 1 in the form +2,250 $21.00 $47,250 2,250 D
Open-market purchases · 2,250 sh · avg $21.00 · $47,250
Loading xslF345X03/doc4.xml…